We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • ONCOLOGY
  • News
  • Blogs
  • Topics
  • Hematology
  • Image IQ
  • Podcasts
  • Videos
  • Slideshows
  • Conferences

SUBSCRIBE: Print / eNewsletter

An Overview of Adenocarcinoma of the Small Intestine

  • Daniel G. Coit, MD, FACS
Apr 1, 1997
Volume: 
11
Issue: 
4

Neugut and colleagues have compiled a very comprehensive, thoughtful
description of the incidence, epidemiology, etiology, clinical presentation,
and treatment of small bowel malignancies. This is a very unusual tumor
that few clinicians will encounter during their careers, and fewer still
will diagnose preoperatively.

I certainly concur with the authors' statement that surgical intervention
provides the only hope of cure for these patients. I disagree, however,
that small bowel tumors are unresectable when there are metastases to regional
lymph nodes. In general, patients with small intestinal adenocarcinomas
are managed with aggressive regional mesenteric lymphadenectomy, even when
the nodes are clinically negative. Survival among patients with positive
nodes is certainly seen in this disease. The local criteria of unresectability
include involvement of central, as opposed to peripheral, mesenteric vessels.

Role of Radiation Therapy

With regard to the role of radiation therapy, one of the reasons that
it is inappropriate relates to the mobility of the small bowel; this mobility
makes it exceedingly difficult to define a treatment field. In theory,
what is appealing about intraoperative radiation therapy is its ability
to define a field at risk for locoregional recurrence while at the same
time excluding adjacent viscera from that field.

Finally, with respect to the appropriate treatment of duodenal adenocarcinoma,
it is extremely difficult in small retrospective series to separate the
impact of treatment from that of patient selection. One would expect that
patients with unresectable disease treated with chemotherapy and/or radiation
therapy would have more advanced disease, and thus, would not do as well
as those who are potentially resectable with pancreaticoduodenectomy. I
agree with the authors that the extent of surgical resection is not a uniform
predictor of improved outcome.

The authors are to be commended for very succinctly summarizing the
current state of knowledge about this unusual tumor. They have emphasized
the frustration we all feel in dealing with unusual malignancies: Given
the nearly insurmountable difficulties in mounting large cooperative prospective
trials, we are unlikely to know much more about the biology or treatment
of there "orphan diseases" 10 years from now.

Resource Topics rightRail

  • Resource Topics
  • Partner Content
Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Melanoma
Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sézary Syndrome
3 Keys to Success in the Oncology Care Model

Current Issue

Oncology Vol 32 No 4
Apr 15, 2018 Vol 32 No 4
Digital Edition
Subscribe
Connect with Us
  • Twitter
  • Facebook
  • LinkedIn
  • RSS
Modern Medicine Network
  • Home
  • About Us
  • Advertise
  • Advertiser Terms
  • Privacy statement
  • Terms & Conditions
  • Editorial & Advertising Policy
  • Editorial Board
  • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.